Overview

Gender

male

Robert Carpenter is Chairman of Hydra Biosciences Inc., a company he helped found which is conducting research in a new class of ion channels.

Previously, he served as Executive Vice President of Genzyme Corporation, and founded two life sciences companies, Integrated Genetics and GelTex Pharmaceuticals, that went public and were acquired by Genzyme. He was a Director of Genzyme from 1994 to 2010 and held the position of Lead Director from 2008 to 2010.

In 2002, Mr. Carpenter also helped spin out a subsidiary of Genzyme called Peptimmune Inc., of which he was Chairman of the Board until 2007. He currently serves as a director of Moderna, Good Start Genetics, SynapDx and Immuneering Inc..

He holds a BA from the United States Military Academy at West Point, an MS in Computer Science from Stanford University, and an MBA from Harvard University.